Recruitment for Phase III clinical trials to assess the efficacy and safety of bepirovirsen is also underway, with results expected in early 2026 (NCT05630807 and NCT05630820)
The compound is distinguished from BPC-157 by its systemic mechanism of action, while BPC-157 is thought to act locally at injury sites, TB-500 promotes cell migration and differentiation throughout the body by sequestering G-actin monomers and regulating cytoskeletal dynamics
Deeply hydrating glutathione plumps skin with moisture to soothe the appearance of fine lines, wrinkles and pore size, while Kojic acid leaves
In a human lung tissue model of TB granulomas, marimastat blocked both granuloma formation and mycobacterial growth [45]
Dillioglugil MO, Maral Kir H, Gulkac MD, Ozon Kanli A, Ozdogan HK, Acar O, et al
Research teams have reported investigation of BPC-157 in models involving tendon and ligament biology, skeletal muscle and bone related endpoints, gastrointestinal mucosal integrity, and broader inflammatory signaling questions, with findings typically framed as mechanistic exploration rather than clinical outcomes.
